Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
Cancer Letters|January 18, 2017
BMP4 promotes metastasis of hepatocellular carcinoma by an induction of epithelial-mesenchymal transition via upregulating ID2Shan Zeng, Yan Zhang, Junli Ma, et al.Biological Procedures Online|June 2, 2023
A multi-omics analysis reveals CLSPN is associated with prognosis, immune microenvironment and drug resistance in cancersYihong Chen, Haicheng Wen, Yin Li, et al.Frontiers in Oncology|July 5, 2021
M6A "Writer" Gene METTL14: A Favorable Prognostic Biomarker and Correlated With Immune Infiltrates in Rectal CancerChangjing Cai, Jie Long, Qiaoqiao Huang, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 17, 2020
MLH1 Deficiency Induces Cetuximab Resistance in Colon Cancer via Her-2/PI3K/AKT SignalingYing Han, Yinghui Peng, Yaojie Fu, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|August 8, 2021
A comprehensive analysis of the efficacy and safety of COVID-19 vaccinesChangjing Cai, Yinghui Peng, Edward Shen, et al.Iscience|January 30, 2023
MTFR2 shapes a barrier of immune microenvironment in hepatocellular carcinomaQiaoqiao Huang, Ying Han, Edward Shen, et al.Iscience|July 26, 2024
Neuromedin U receptor 1 deletion leads to impaired immunotherapy response and high malignancy in colorectal cancerYulai Zhou, Xiangyang Zhang, Yan Gao, et al.Journal of Experimental & Clinical Cancer Research : CR|January 23, 2022
tRF3008A suppresses the progression and metastasis of colorectal cancer by destabilizing FOXK1 in an AGO-dependent mannerYing Han, Yinghui Peng, Shanshan Liu, et al.Iscience|March 19, 2026
Erratum: Neuromedin U receptor 1 deletion leads to impaired immunotherapy response and high malignancy in colorectal cancerYulai Zhou, Xiangyang Zhang, Yan Gao, et al.Frontiers in Pharmacology|October 17, 2022
The optimal first-line treatment for patients with left-sided RAS wild-type metastatic colorectal cancer: Double-drug regimen or triple-drug regimen therapyChangjing Cai, Qingqing Luo, Yihan Liu, et al.Pageof 5